Friday, November 7, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Sell Rating on Stellus Capital Investment with Lower Price Target

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On March 6, 2024, Bryce Rowe, an analyst at B. Riley Securities, reaffirmed his Sell rating on Stellus Capital Investment (NYSE: SCM) and adjusted the price target to $12.50, down from $13. This update comes after Stellus Capital Investment was downgraded from Neutral to Sell by B. Riley, citing a changing market environment. The previous price target of $13 has been revised in light of these developments.

SCM Stock Performance Shows Interesting Movements on March 6, 2024

On March 6, 2024, SCM’s stock performance showed some interesting movements. According to data from CNN Money, SCM was trading near the bottom of its 52-week range and below its 200-day simple moving average. This indicates that the stock may be experiencing some downward pressure.

However, on that particular day, there was a slight uptick in the price of SCM shares. The stock had increased by $0.22 since the market last closed, representing a 1.73% rise. This brought the closing price of SCM shares to $12.97.

Despite this initial increase, the stock experienced a drop of $0.09 in pre-market trading. This drop may have been influenced by various factors such as market sentiment, economic indicators, or company-specific news.

SCM Stock Performance Analysis: Revenue Decline and Net Loss Raise Concerns for Investors

On March 6, 2024, SCM stock experienced a mixed performance based on the latest financial data provided by CNN Money. The company’s total revenue for the past year was $78.77 million, a decrease of 9.86% compared to the previous year. However, the total revenue for the third quarter was $27.77 million, showing an increase of 5.67% from the previous quarter.

In terms of net income, SCM reported a net income of $14.49 million for the past year, which represents a significant decrease of 56.83% compared to the previous year. The net income for the third quarter was -$2.40 million, indicating a loss for that period and a decrease of 164.6% from the previous quarter.

Earnings per share (EPS) also saw a decline for SCM stock. The EPS for the past year was $0.74, a decrease of 56.97% compared to the previous year. The EPS for the third quarter was -$0.10, showing a loss per share and a decrease of 160.07% from the previous quarter.

Overall, these financial indicators suggest that SCM stock has faced challenges in terms of revenue, net income, and earnings per share. Investors may be concerned about the company’s performance and future prospects based on these figures. It is important for investors to closely monitor SCM’s financial performance and any updates from the company to make informed decisions about their investments in the stock.

Tags: SCM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

Harvard Bioscience Inc Unveils CuttingEdge Product Advancements for Research at SOT Conference

The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation

BTIG Analyst Gray Powell Optimistic about HashiCorps Future Growth

Groundbreaking Clinical Study Shows Effectiveness of AVIM Therapy in Hypertensive Pacemaker Patients

Recommended

Armour Residential Reit Stock

Armour Residential REIT: A Dividend Maintained Amid Operational Divergence

2 months ago
DVY stock news

Atlantica Sustainable NASDAQ AY Announces Quarterly Dividend Distribution

2 years ago
Lockheed Martin Stock

Lockheed Martin Stock: Defense Giant Secures Major Contracts and Boosts Shareholder Returns

4 weeks ago
T-Mobile US Stock

T-Mobile US Accelerates Integration Strategy Amid Industry Transformation

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ouster’s Market Paradox: Record Revenue Meets Investor Skepticism

Warner Bros. Discovery at a Strategic Crossroads

Pivotal Week Ahead for Skye Bioscience with Key Data and Financial Results

Dillard’s Faces Critical Earnings Test Amid Divergent Analyst Views

Cellectar Shares Gain as Key Catalysts Approach

Core Scientific’s Strategic Pivot Gains Momentum Amid Legal Resolution

Trending

Applied Materials Stock
Analysis

Applied Materials Faces Critical Test as Institutional Backing Grows

by Andreas Sommer
November 7, 2025
0

While the semiconductor sector continues to face significant headwinds, Applied Materials finds itself at a pivotal juncture....

Gladstone Commercial Stock

Gladstone Commercial Faces Investor Concerns After Disappointing Earnings

November 7, 2025
ThredUp Stock

ThredUp Shares Surge on Stellar Quarterly Performance

November 7, 2025
Ouster Stock

Ouster’s Market Paradox: Record Revenue Meets Investor Skepticism

November 7, 2025
Warner Bros. Discovery (A) Stock

Warner Bros. Discovery at a Strategic Crossroads

November 7, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Applied Materials Faces Critical Test as Institutional Backing Grows
  • Gladstone Commercial Faces Investor Concerns After Disappointing Earnings
  • ThredUp Shares Surge on Stellar Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com